Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Guidelines for the diagnosis and management of intrahepatic cholangiocarcinoma
John Bridgewater, Peter R. Galle, Shahid A. Khan, et al.
Journal of Hepatology (2014) Vol. 60, Iss. 6, pp. 1268-1289
Open Access | Times Cited: 1333

Showing 1-25 of 1333 citing articles:

Cholangiocarcinoma 2020: the next horizon in mechanisms and management
Jesús M. Bañales, José J.G. Marı́n, Ángela Lamarca, et al.
Nature Reviews Gastroenterology & Hepatology (2020) Vol. 17, Iss. 9, pp. 557-588
Open Access | Times Cited: 1722
Evidence-Based Diagnosis, Staging, and Treatment of Patients With Hepatocellular Carcinoma
Jordi Bruix, María Reig, Morris Sherman
Gastroenterology (2016) Vol. 150, Iss. 4, pp. 835-853
Open Access | Times Cited: 1571
Cholangiocarcinoma — evolving concepts and therapeutic strategies
Sumera I. Ilyas, Shahid A. Khan, Christopher L. Hallemeier, et al.
Nature Reviews Clinical Oncology (2017) Vol. 15, Iss. 2, pp. 95-111
Open Access | Times Cited: 1353
Human primary liver cancer–derived organoid cultures for disease modeling and drug screening
Laura Broutier, Gianmarco Mastrogiovanni, Monique M.A. Verstegen, et al.
Nature Medicine (2017) Vol. 23, Iss. 12, pp. 1424-1435
Open Access | Times Cited: 1173
Cholangiocarcinoma: current knowledge and future perspectives consensus statement from the European Network for the Study of Cholangiocarcinoma (ENS-CCA)
Jesús M. Bañales, Vincenzo Cardinale, Guido Carpino, et al.
Nature Reviews Gastroenterology & Hepatology (2016) Vol. 13, Iss. 5, pp. 261-280
Open Access | Times Cited: 1123
Liver Cancer Cell of Origin, Molecular Class, and Effects on Patient Prognosis
Daniela Sia, Augusto Villanueva, Scott L. Friedman, et al.
Gastroenterology (2016) Vol. 152, Iss. 4, pp. 745-761
Open Access | Times Cited: 1009
Capecitabine compared with observation in resected biliary tract cancer (BILCAP): a randomised, controlled, multicentre, phase 3 study
John Primrose, Richard Fox, Daniel H. Palmer, et al.
The Lancet Oncology (2019) Vol. 20, Iss. 5, pp. 663-673
Open Access | Times Cited: 986
EASL Clinical Practice Guidelines: Liver transplantation

Journal of Hepatology (2015) Vol. 64, Iss. 2, pp. 433-485
Closed Access | Times Cited: 929
The immunology of hepatocellular carcinoma
Marc Ringelhan, Dominik Pfister, Tracy O’Connor, et al.
Nature Immunology (2018) Vol. 19, Iss. 3, pp. 222-232
Closed Access | Times Cited: 862
Forty-Year Trends in Cholangiocarcinoma Incidence in the U.S.: Intrahepatic Disease on the Rise
Supriya K. Saha, Andrew X. Zhu, Charles S. Fuchs, et al.
The Oncologist (2016) Vol. 21, Iss. 5, pp. 594-599
Open Access | Times Cited: 668
Cholangiocarcinoma: Epidemiology and risk factors
Shahid A. Khan, Simona Tavolari, Giovanni Brandi
Liver International (2019) Vol. 39, Iss. S1, pp. 19-31
Open Access | Times Cited: 613
Cholangiocarcinoma: Current Knowledge and New Developments
Boris Blechacz
Gut and Liver (2016) Vol. 11, Iss. 1, pp. 13-26
Open Access | Times Cited: 440
Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma
Jittiporn Chaisaingmongkol, Anuradha Budhu, Hien Dang, et al.
Cancer Cell (2017) Vol. 32, Iss. 1, pp. 57-70.e3
Open Access | Times Cited: 368
Liver transplantation for “very early” intrahepatic cholangiocarcinoma: International retrospective study supporting a prospective assessment
Gonzalo Sapisochín, Marcelo Facciuto, Laura Rubbia‐Brandt, et al.
Hepatology (2016) Vol. 64, Iss. 4, pp. 1178-1188
Open Access | Times Cited: 315
Functional and genetic deconstruction of the cellular origin in liver cancer
Jens U. Marquardt, Jesper B. Andersen, Snorri S. Thorgeirsson
Nature reviews. Cancer (2015) Vol. 15, Iss. 11, pp. 653-667
Closed Access | Times Cited: 289
Intrahepatic cholangiocarcinoma: Epidemiology, risk factors, diagnosis and surgical management
Han Zhang, Tian Yang, Mengchao Wu, et al.
Cancer Letters (2015) Vol. 379, Iss. 2, pp. 198-205
Closed Access | Times Cited: 283
Massive parallel sequencing uncovers actionable FGFR2–PPHLN1 fusion and ARAF mutations in intrahepatic cholangiocarcinoma
Daniela Sia, Bojan Losic, Agrin Moeini, et al.
Nature Communications (2015) Vol. 6, Iss. 1
Open Access | Times Cited: 279
Intrahepatic Cholangiocarcinoma: Continuing Challenges and Translational Advances
Alphonse E. Sirica, Gregory J. Gores, John D. Groopman, et al.
Hepatology (2018) Vol. 69, Iss. 4, pp. 1803-1815
Open Access | Times Cited: 273
Liver resection and transplantation for intrahepatic cholangiocarcinoma
Vincenzo Mazzaferro, Andre Gorgen, Sasan Roayaie, et al.
Journal of Hepatology (2020) Vol. 72, Iss. 2, pp. 364-377
Open Access | Times Cited: 271
Liver cancer: Approaching a personalized care
Jordi Bruix, Kwang–Hyub Han, Gregory J. Gores, et al.
Journal of Hepatology (2015) Vol. 62, Iss. 1, pp. S144-S156
Open Access | Times Cited: 267
Cancer and liver cirrhosis: implications on prognosis and management
Matthias Pinter, Michael Trauner, Markus Peck‐Radosavljevic, et al.
ESMO Open (2016) Vol. 1, Iss. 2, pp. e000042-e000042
Open Access | Times Cited: 256
Molecular Pathogenesis of Cholangiocarcinoma
Peter Labib, George Goodchild, Stephen P. Pereira
BMC Cancer (2019) Vol. 19, Iss. 1
Open Access | Times Cited: 255
Clinical presentation, diagnosis and staging of cholangiocarcinoma
Alejandro Forner, Gianpaolo Vidili, Marco Rengo, et al.
Liver International (2019) Vol. 39, Iss. S1, pp. 98-107
Open Access | Times Cited: 252
Radioembolization Plus Chemotherapy for First-line Treatment of Locally Advanced Intrahepatic Cholangiocarcinoma
Julien Edeline, Yann Touchefeu, Boris Guiu, et al.
JAMA Oncology (2019) Vol. 6, Iss. 1, pp. 51-51
Open Access | Times Cited: 239
PD-L1, TMB, MSI, and Other Predictors of Response to Immune Checkpoint Inhibitors in Biliary Tract Cancer
Alessandro Rizzo, Angela Dalia Ricci, Giovanni Brandi
Cancers (2021) Vol. 13, Iss. 3, pp. 558-558
Open Access | Times Cited: 234
Page 1 - Next Page

Scroll to top